Research Solutions, Inc. (NASDAQ:RSSS – Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 73,700 shares, an increase of 75.5% from the February 28th total of 42,000 shares. Approximately 0.3% of the company’s shares are short sold. Based on an average daily trading volume, of 128,000 shares, the short-interest ratio is currently 0.6 days.
Research Solutions Trading Down 1.9 %
RSSS traded down $0.05 during midday trading on Friday, hitting $2.65. The company’s stock had a trading volume of 28,290 shares, compared to its average volume of 87,449. Research Solutions has a 52-week low of $2.38 and a 52-week high of $4.24. The firm has a 50-day moving average price of $3.32 and a two-hundred day moving average price of $3.25. The firm has a market cap of $86.51 million, a P/E ratio of -17.67, a PEG ratio of 4.33 and a beta of 0.55.
Research Solutions (NASDAQ:RSSS – Get Free Report) last released its earnings results on Thursday, February 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.09). Research Solutions had a negative net margin of 8.41% and a negative return on equity of 6.59%. The company had revenue of $11.91 million during the quarter, compared to analysts’ expectations of $11.86 million. On average, equities analysts expect that Research Solutions will post 0.05 EPS for the current year.
Institutional Trading of Research Solutions
Research Solutions Company Profile
Research Solutions, Inc, through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover platform that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including free basic search solutions and advanced search tools, which include the Resolute.ai and scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer’s internal datasets.
Further Reading
- Five stocks we like better than Research Solutions
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- MarketBeat Week in Review – 03/24 – 03/28
- Investing In Preferred Stock vs. Common Stock
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- What Are Growth Stocks and Investing in Them
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Research Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Research Solutions and related companies with MarketBeat.com's FREE daily email newsletter.